2022 Q1 Form 10-K Financial Statement
#000156459022006702 Filed on February 24, 2022
Income Statement
Concept | 2022 Q1 | 2021 Q4 | 2021 |
---|---|---|---|
Revenue | $11.99M | $12.52M | $75.44M |
YoY Change | -31.08% | -31.98% | 15.81% |
Cost Of Revenue | $2.284M | $11.43M | $36.96M |
YoY Change | -69.95% | 81.49% | 145.01% |
Gross Profit | $994.0K | $1.081M | $38.49M |
YoY Change | -89.86% | -91.14% | -23.12% |
Gross Profit Margin | 8.29% | 8.64% | 51.01% |
Selling, General & Admin | $20.70M | $22.73M | $77.42M |
YoY Change | 18.86% | 32.91% | 31.13% |
% of Gross Profit | 2082.19% | 2102.41% | 201.16% |
Research & Development | $3.536M | $3.886M | $12.31M |
YoY Change | 44.8% | -73.74% | 97.06% |
% of Gross Profit | 355.73% | 359.48% | 31.99% |
Depreciation & Amortization | $599.0K | $1.220M | $2.000M |
YoY Change | 30.22% | 139.22% | 11.11% |
% of Gross Profit | 60.26% | 112.86% | 5.2% |
Operating Expenses | $24.23M | $26.61M | $89.73M |
YoY Change | 22.05% | -16.57% | 37.44% |
Operating Profit | -$23.24M | -$25.53M | -$47.02M |
YoY Change | 131.12% | 29.6% | -1.86% |
Interest Expense | -$2.759M | -$2.530M | -$9.898M |
YoY Change | 6.12% | -60.47% | -42.79% |
% of Operating Profit | |||
Other Income/Expense, Net | $0.00 | $1.000K | -$239.0K |
YoY Change | -100.0% | ||
Pretax Income | -$26.00M | -$28.06M | -$80.93M |
YoY Change | 101.29% | 6.29% | 40.84% |
Income Tax | $0.00 | $0.00 | $0.00 |
% Of Pretax Income | |||
Net Earnings | -$26.00M | -$28.06M | -$80.93M |
YoY Change | 101.29% | 6.29% | 41.38% |
Net Earnings / Revenue | -216.79% | -224.22% | -107.27% |
Basic Earnings Per Share | -$0.10 | -$0.32 | |
Diluted Earnings Per Share | -$103.2K | -$111.8K | -$324.7K |
COMMON SHARES | |||
Basic Shares Outstanding | 251.8M | 249.2M | |
Diluted Shares Outstanding | 251.9M | 249.2M |
Balance Sheet
Concept | 2022 Q1 | 2021 Q4 | 2021 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $162.4M | $204.1M | $204.1M |
YoY Change | -41.31% | 204.65% | 204.65% |
Cash & Equivalents | $67.24M | $124.2M | $124.2M |
Short-Term Investments | $95.20M | $79.93M | $79.93M |
Other Short-Term Assets | $3.952M | $3.482M | $3.482M |
YoY Change | 31.73% | 5.52% | 5.52% |
Inventory | $8.044M | $7.152M | $7.152M |
Prepaid Expenses | |||
Receivables | $9.823M | $4.739M | $4.994M |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $184.3M | $219.7M | $219.7M |
YoY Change | -36.09% | 176.49% | 176.41% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $41.45M | $36.61M | $36.61M |
YoY Change | 56.39% | 41.54% | 41.36% |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | $70.54M | $56.62M | $56.62M |
YoY Change | 4602.8% | ||
Other Assets | $12.06M | $8.186M | $8.186M |
YoY Change | 288.97% | 150.72% | 148.06% |
Total Long-Term Assets | $124.1M | $101.4M | $101.4M |
YoY Change | 298.88% | 248.13% | 248.51% |
TOTAL ASSETS | |||
Total Short-Term Assets | $184.3M | $219.7M | $219.7M |
Total Long-Term Assets | $124.1M | $101.4M | $101.4M |
Total Assets | $308.3M | $321.2M | $321.2M |
YoY Change | -3.47% | 195.71% | 195.73% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $8.702M | $6.956M | $6.956M |
YoY Change | 29.88% | 24.61% | 24.21% |
Accrued Expenses | $27.13M | $27.42M | $24.35M |
YoY Change | -1.65% | 39.13% | 39.15% |
Deferred Revenue | $827.0K | ||
YoY Change | -97.51% | ||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | $9.410M | $6.977M | $6.977M |
YoY Change | 100.21% | 70.17% | 70.17% |
Total Short-Term Liabilities | $53.49M | $48.35M | $48.35M |
YoY Change | -26.82% | -34.4% | -34.4% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $375.1M | $374.7M | $374.7M |
YoY Change | 15.11% | 217.03% | 217.03% |
Other Long-Term Liabilities | $7.054M | $4.950M | $107.4M |
YoY Change | -92.5% | -94.9% | 10.64% |
Total Long-Term Liabilities | $7.054M | $4.950M | $482.2M |
YoY Change | -98.32% | -97.7% | 123.95% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $53.49M | $48.35M | $48.35M |
Total Long-Term Liabilities | $7.054M | $4.950M | $482.2M |
Total Liabilities | $540.4M | $530.5M | $530.5M |
YoY Change | 9.61% | 83.55% | 83.57% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$3.156B | -$3.100B | |
YoY Change | 1.81% | 1.67% | |
Common Stock | $2.921B | ||
YoY Change | 1.81% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$232.1M | -$209.3M | -$209.3M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $308.3M | $321.2M | $321.2M |
YoY Change | -3.47% | 195.71% | 195.73% |
Cashflow Statement
Concept | 2022 Q1 | 2021 Q4 | 2021 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$26.00M | -$28.06M | -$80.93M |
YoY Change | 101.29% | 6.29% | 41.38% |
Depreciation, Depletion And Amortization | $599.0K | $1.220M | $2.000M |
YoY Change | 30.22% | 139.22% | 11.11% |
Cash From Operating Activities | -$18.25M | -$12.35M | -$61.71M |
YoY Change | 43.34% | -5468.26% | 119.39% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $5.056M | -$5.190M | -$11.47M |
YoY Change | 418.03% | 15.85% | -1531.46% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | -$34.45M | -$7.389M | -$140.1M |
YoY Change | 13.17% | -800.36% | |
Cash From Investing Activities | -$39.51M | -$12.58M | -$151.5M |
YoY Change | 25.74% | 180.78% | -1095.91% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 813.0K | 97.37M | 270.3M |
YoY Change | -99.64% | 420.97% | 442.13% |
NET CHANGE | |||
Cash From Operating Activities | -18.25M | -12.35M | -61.71M |
Cash From Investing Activities | -39.51M | -12.58M | -151.5M |
Cash From Financing Activities | 813.0K | 97.37M | 270.3M |
Net Change In Cash | -56.94M | 72.44M | 57.02M |
YoY Change | -131.49% | 401.69% | 54.36% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$18.25M | -$12.35M | -$61.71M |
Capital Expenditures | $5.056M | -$5.190M | -$11.47M |
Free Cash Flow | -$23.30M | -$7.157M | -$50.24M |
YoY Change | 70.02% | -251.95% | 73.68% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2021Q4 | us-gaap |
Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
|
http://fasb.org/us-gaap/2021-01-31#OtherAssets | |
CY2021 | mnkd |
Longterm Purchase Commitment Renewal Time Period
LongtermPurchaseCommitmentRenewalTimePeriod
|
P2Y | |
CY2021Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2020Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2021Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
CY2020Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
CY2020 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
|
0.0039 | |
CY2020 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
|
0.9383 | |
CY2020 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
|
0.0152 | |
CY2020 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P6Y5M12D | |
CY2021 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P5Y9M25D | |
CY2021 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
|
P5Y6M29D | |
CY2021Q4 | us-gaap |
Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
|
P19Y9M18D | |
CY2020Q4 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P1Y10M24D | |
CY2020 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-218000 | |
CY2021Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
124184000 | |
CY2020Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
67005000 | |
CY2020Q4 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
158000 | |
CY2021Q4 | us-gaap |
Short Term Investments
ShortTermInvestments
|
79932000 | |
CY2020Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
4218000 | |
CY2020Q4 | us-gaap |
Inventory Net
InventoryNet
|
4973000 | |
CY2020Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
3122000 | |
CY2020Q4 | us-gaap |
Assets Current
AssetsCurrent
|
79476000 | |
CY2020Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
25867000 | |
CY2021Q4 | us-gaap |
Long Term Investments
LongTermInvestments
|
56619000 | |
CY2021Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
8186000 | |
CY2020Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
3265000 | |
CY2021Q4 | us-gaap |
Assets
Assets
|
321161000 | |
CY2020Q4 | us-gaap |
Assets
Assets
|
108608000 | |
CY2021Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
6956000 | |
CY2020Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
5582000 | |
CY2021Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
27419000 | |
CY2020Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
19707000 | |
CY2021Q4 | us-gaap |
Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
|
6977000 | |
CY2020Q4 | mnkd |
Paycheck Protection Program Loan Current
PaycheckProtectionProgramLoanCurrent
|
4061000 | |
CY2021Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
827000 | |
CY2020Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
33275000 | |
CY2021Q4 | mnkd |
Purchase Obligation Current
PurchaseObligationCurrent
|
6170000 | |
CY2020Q4 | mnkd |
Purchase Obligation Current
PurchaseObligationCurrent
|
11080000 | |
CY2021Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
48349000 | |
CY2020Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
73705000 | |
CY2021Q4 | mnkd |
Promissory Notes Noncurrent
PromissoryNotesNoncurrent
|
18425000 | |
CY2020Q4 | mnkd |
Promissory Notes Noncurrent
PromissoryNotesNoncurrent
|
63027000 | |
CY2021Q4 | mnkd |
Credit Facility Noncurrent
CreditFacilityNoncurrent
|
38833000 | |
CY2020Q4 | mnkd |
Credit Facility Noncurrent
CreditFacilityNoncurrent
|
49335000 | |
CY2021Q4 | us-gaap |
Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
|
223944000 | |
CY2021Q4 | mnkd |
Purchase Obligation Noncurrent
PurchaseObligationNoncurrent
|
76659000 | |
CY2020Q4 | mnkd |
Purchase Obligation Noncurrent
PurchaseObligationNoncurrent
|
84208000 | |
CY2021Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
1040000 | |
CY2020Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
1202000 | |
CY2021Q4 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
19543000 | |
CY2020Q4 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
1662000 | |
CY2021Q4 | mnkd |
Milestone Rights Liabilities Noncurrent
MilestoneRightsLiabilitiesNoncurrent
|
4838000 | |
CY2020Q4 | mnkd |
Milestone Rights Liabilities Noncurrent
MilestoneRightsLiabilitiesNoncurrent
|
5926000 | |
CY2020Q4 | us-gaap |
Senior Long Term Notes
SeniorLongTermNotes
|
5000000 | |
CY2020Q4 | mnkd |
Paycheck Protection Program Loan Noncurrent
PaycheckProtectionProgramLoanNoncurrent
|
812000 | |
CY2021Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
4950000 | |
CY2021Q4 | us-gaap |
Liabilities
Liabilities
|
530510000 | |
CY2020Q4 | us-gaap |
Liabilities
Liabilities
|
289027000 | |
CY2021Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
CY2020Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
CY2021Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | |
CY2020Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | |
CY2021Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2020Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2021Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2020Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2021Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2020Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
400000000 | |
CY2020Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
400000000 | |
CY2021Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
251477562 | |
CY2021Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
251477562 | |
CY2020Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
242117089 | |
CY2020Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
242117089 | |
CY2021Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
2515000 | |
CY2020Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
2421000 | |
CY2021Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
2918205000 | |
CY2020Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
2866303000 | |
CY2021Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-3130069000 | |
CY2020Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-3049143000 | |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-209349000 | |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-180419000 | |
CY2021Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
321161000 | |
CY2021 | us-gaap |
Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
|
38000 | |
CY2020Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
108608000 | |
CY2020 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
65144000 | |
CY2020 | us-gaap |
Research And Development In Process
ResearchAndDevelopmentInProcess
|
13233000 | |
CY2021 | us-gaap |
Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
12312000 | |
CY2021 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
77417000 | |
CY2020 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
59040000 | |
CY2021 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
106000 | |
CY2020 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
1889000 | |
CY2021 | us-gaap |
Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
|
6567000 | |
CY2020 | us-gaap |
Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
|
-8006000 | |
CY2021 | mnkd |
Gain Loss On Purchase Commitments
GainLossOnPurchaseCommitments
|
-339000 | |
CY2021 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
122464000 | |
CY2020 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
113057000 | |
CY2021 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-47022000 | |
CY2020 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-47913000 | |
CY2021 | mnkd |
Interest Expense On Financing Liability
InterestExpenseOnFinancingLiability
|
1373000 | |
CY2021 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.32 | |
CY2020 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.26 | |
CY2021 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
249244000 | |
CY2020 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
222585000 | |
CY2020 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
|
-19000 | |
CY2021 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-80926000 | |
CY2020 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-57259000 | |
CY2019Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-190526000 | |
CY2020 | mnkd |
Stock Issued During Period Value Stock Options And Restricted Stock Units Net Of Forfeitures
StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures
|
233000 | |
CY2020 | us-gaap |
Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
|
519000 | |
CY2020 | us-gaap |
Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
|
9250000 | |
CY2020 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
6511000 | |
CY2020 | mnkd |
Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
|
11600000 | |
CY2020 | mnkd |
Stock Issued During Period Value Market Price Stock Purchase Plan
StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan
|
215000 | |
CY2020 | mnkd |
Adjustments To Additional Paid In Capital Issuance Of Warrants Pursuant To Credit Facility
AdjustmentsToAdditionalPaidInCapitalIssuanceOfWarrantsPursuantToCreditFacility
|
275000 | |
CY2020 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
|
-19000 | |
CY2020 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-57240000 | |
CY2021 | mnkd |
Stock Issued During Period Value Stock Options And Restricted Stock Units Net Of Forfeitures
StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures
|
-498000 | |
CY2021 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
1090000 | |
CY2021 | us-gaap |
Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
|
10000000 | |
CY2020 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
793000 | |
CY2020 | mnkd |
Increase Decrease In Recognized Loss On Purchase Commitments
IncreaseDecreaseInRecognizedLossOnPurchaseCommitments
|
-4751000 | |
CY2021 | mnkd |
Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
|
-2135000 | |
CY2020 | mnkd |
Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
|
-1312000 | |
CY2021 | mnkd |
Increase Decrease In Accrued Interest On Promissory Notes
IncreaseDecreaseInAccruedInterestOnPromissoryNotes
|
4919000 | |
CY2021 | us-gaap |
Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
|
4950000 | |
CY2021 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-61709000 | |
CY2021 | mnkd |
Adjustment To Additional Paid In Capital Premium On Convertible Note
AdjustmentToAdditionalPaidInCapitalPremiumOnConvertibleNote
|
22107000 | |
CY2021 | mnkd |
Stock Issued During Period Value Market Price Stock Purchase Plan
StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan
|
106000 | |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-80926000 | |
CY2020 | us-gaap |
Profit Loss
ProfitLoss
|
-57240000 | |
CY2021 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-17200000 | |
CY2020 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-264000 | |
CY2021 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
12200000 | |
CY2021 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
4215000 | |
CY2020 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
2149000 | |
CY2021 | mnkd |
Interest On Milestone Payment
InterestOnMilestonePayment
|
3663000 | |
CY2021 | us-gaap |
Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
|
1902000 | |
CY2020 | us-gaap |
Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
|
496000 | |
CY2021 | mnkd |
Interest Expense On Promissory Notes
InterestExpenseOnPromissoryNotes
|
1598000 | |
CY2020 | mnkd |
Interest Expense On Promissory Notes
InterestExpenseOnPromissoryNotes
|
5148000 | |
CY2021 | mnkd |
Amortization Of Financing Liability
AmortizationOfFinancingLiability
|
1372000 | |
CY2021 | mnkd |
Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
|
1258000 | |
CY2020 | mnkd |
Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
|
1177000 | |
CY2021 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
106000 | |
CY2020 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
1889000 | |
CY2021 | us-gaap |
Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
|
6567000 | |
CY2020 | us-gaap |
Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
|
-8006000 | |
CY2020 | us-gaap |
Research And Development In Process
ResearchAndDevelopmentInProcess
|
13233000 | |
CY2020 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
-19000 | |
CY2021 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
776000 | |
CY2020 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
705000 | |
CY2021 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
4081000 | |
CY2020 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
1314000 | |
CY2021 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
360000 | |
CY2020 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
154000 | |
CY2021 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
138000 | |
CY2020 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-227000 | |
CY2021 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
1374000 | |
CY2021 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
8814000 | |
CY2020 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
3346000 | |
CY2021 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-14567000 | |
CY2020 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-5910000 | |
CY2021 | mnkd |
Increase Decrease In Recognized Loss On Purchase Commitments
IncreaseDecreaseInRecognizedLossOnPurchaseCommitments
|
-5892000 | |
CY2020 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-28128000 | |
CY2021 | us-gaap |
Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
|
196131000 | |
CY2021 | us-gaap |
Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
|
59060000 | |
CY2020 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
801000 | |
CY2021 | mnkd |
Purchase Of Available For Sale Securities
PurchaseOfAvailableForSaleSecurities
|
3000000 | |
CY2020 | us-gaap |
Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
|
20000000 | |
CY2020 | us-gaap |
Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
|
3983000 | |
CY2021 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-151537000 | |
CY2020 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
15216000 | |
CY2021 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
230000000 | |
CY2021 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
7268000 | |
CY2021 | mnkd |
Proceeds From Sale Leaseback Transaction
ProceedsFromSaleLeasebackTransaction
|
102250000 | |
CY2021 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
3120000 | |
CY2021 | mnkd |
Deposit For Sale Leaseback Transaction
DepositForSaleLeasebackTransaction
|
2000000 | |
CY2021 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
35051000 | |
CY2021Q4 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
288400000 | |
CY2021Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-3100000000 | |
CY2021Q4 | us-gaap |
Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
|
103733000 | |
CY2021 | mnkd |
Payment Of Credit Facility Prepayment Penalty
PaymentOfCreditFacilityPrepaymentPenalty
|
1000000 | |
CY2021 | mnkd |
Milestone Payments
MilestonePayments
|
5000000 | |
CY2021 | mnkd |
Payments Related To Employment Taxes For Share Based Compensation And Proceeds From Exercise Of Stock Options
PaymentsRelatedToEmploymentTaxesForShareBasedCompensationAndProceedsFromExerciseOfStockOptions
|
498000 | |
CY2020 | mnkd |
Payments Related To Employment Taxes For Share Based Compensation And Proceeds From Exercise Of Stock Options
PaymentsRelatedToEmploymentTaxesForShareBasedCompensationAndProceedsFromExerciseOfStockOptions
|
-233000 | |
CY2021 | us-gaap |
Proceeds From Stock Plans
ProceedsFromStockPlans
|
106000 | |
CY2020 | us-gaap |
Proceeds From Stock Plans
ProceedsFromStockPlans
|
215000 | |
CY2020 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
11600000 | |
CY2020 | us-gaap |
Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
|
10000000 | |
CY2020 | us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
4873000 | |
CY2021 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
270267000 | |
CY2020 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
49853000 | |
CY2021 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
57021000 | |
CY2020 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
36941000 | |
CY2021Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
124200000 | |
CY2021Q4 | us-gaap |
Short Term Investments
ShortTermInvestments
|
79900000 | |
CY2021Q4 | us-gaap |
Long Term Investments
LongTermInvestments
|
56600000 | |
CY2021Q1 | us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
230000000.0 | |
CY2021Q1 | us-gaap |
Debt Conversion Converted Instrument Rate
DebtConversionConvertedInstrumentRate
|
0.0250 | |
CY2021 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Financial Statement Estimates<span style="font-style:normal;"> — The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates or assumptions. Management considers many factors in selecting appropriate financial accounting policies, and in developing the estimates and assumptions that are used in the preparation of the financial statements. Management must apply significant judgment in this process and the COVID-19 pandemic has increased the level of judgment used by management in developing these estimates and assumptions. The COVID-19 pandemic continues to rapidly evolve and the ultimate impact of the COVID-19 pandemic is highly uncertain and subject to change. These effects could have a material impact on the estimates and assumptions used in the preparation of the accompanying consolidated financial statements. The more significant estimates include revenue recognition, including gross-to-net adjustments, stand-alone selling price considerations for recognition of collaboration revenue assessing long-lived assets for impairment, clinical trial expenses, inventory costing and recoverability, recognized loss on purchase commitment, milestone rights liability, stock-based compensation and the determination of the provision for income taxes and corresponding deferred tax assets and liabilities, and the valuation allowance recorded against net deferred tax assets. </span></p> | |
CY2021Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
124184000 | |
CY2020Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
67005000 | |
CY2020Q4 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
158000 | |
CY2021 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
500000 | |
CY2020 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
0 | |
CY2021Q4 | us-gaap |
Debt Securities Held To Maturity Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAllowanceForCreditLoss
|
0 | |
CY2021Q4 | us-gaap |
Held To Maturity Securities Debt Maturities Within One Year Fair Value
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue
|
103669000 | |
CY2020Q4 | us-gaap |
Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
|
59495000 | |
CY2020Q4 | us-gaap |
Held To Maturity Securities Debt Maturities Within One Year Fair Value
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue
|
59495000 | |
CY2021Q4 | us-gaap |
Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount
|
56619000 | |
CY2021Q4 | us-gaap |
Held To Maturity Securities Debt Maturities After One Through Five Years Fair Value
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
|
56433000 | |
CY2021Q4 | us-gaap |
Held To Maturity Securities Debt Maturities Single Maturity Date Amortized Cost Basis
HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
|
160352000 | |
CY2021Q4 | us-gaap |
Held To Maturity Securities Debt Maturities Single Maturity Date Fair Value
HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValue
|
160102000 | |
CY2020Q4 | us-gaap |
Held To Maturity Securities Debt Maturities Single Maturity Date Amortized Cost Basis
HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
|
59495000 | |
CY2020Q4 | us-gaap |
Held To Maturity Securities Debt Maturities Single Maturity Date Fair Value
HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValue
|
59495000 | |
CY2021 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<span style="font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk</span><span style="font-style:normal;"> — Financial instruments that potentially subject the Company to concentration of credit risk consist of cash and cash equivalents</span><span style="font-style:normal;"> and investments</span><span style="font-style:normal;">. Cash and cash equivalents are held in high credit quality institutions. Cash equivalents consist of interest-bearing money market accounts and U.S. </span><span style="font-style:normal;">Treasury securities with maturities less than 90 days. Investments generally consist of commercial paper, corporate notes or bonds and U.S. Treasury securities. The cash equivalents and investments are regularly monitored by management.</span> | |
CY2021Q4 | mnkd |
Accounts Receivable Other
AccountsReceivableOther
|
255000 | |
CY2021Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
4994000 | |
CY2020Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
4218000 | |
CY2021 | mnkd |
Number Of Wholesale Distributors
NumberOfWholesaleDistributors
|
3 | |
CY2021 | mnkd |
Percentage Of Sales From Major Customers
PercentageOfSalesFromMajorCustomers
|
0.80 | |
CY2020 | mnkd |
Percentage Of Sales From Major Customers
PercentageOfSalesFromMajorCustomers
|
0.86 | |
CY2021Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
800000 | |
CY2021 | mnkd |
Percentage Of Sales From Major Customers Collaborations And Services
PercentageOfSalesFromMajorCustomersCollaborationsAndServices
|
0.95 | |
CY2020Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
958000 | |
CY2021Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
27419000 | |
CY2020Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
1393000 | |
CY2021Q4 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
2522000 | |
CY2020Q4 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
2484000 | |
CY2021 | us-gaap |
Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
|
100000 | |
CY2020Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
19707000 | |
CY2021Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
1927000 | |
CY2020Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
1096000 | |
CY2021Q4 | us-gaap |
Inventory Net
InventoryNet
|
7152000 | |
CY2020Q4 | us-gaap |
Inventory Net
InventoryNet
|
4973000 | |
CY2021Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
2703000 | |
CY2021 | us-gaap |
Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
|
1900000 | |
CY2021Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
14022000 | |
CY2020Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
11250000 | |
CY2021Q4 | mnkd |
Customer Discounts And Allowances
CustomerDiscountsAndAllowances
|
4227000 | |
CY2020 | us-gaap |
Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
|
500000 | |
CY2020Q4 | mnkd |
Customer Discounts And Allowances
CustomerDiscountsAndAllowances
|
3688000 | |
CY2021Q4 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
2166000 | |
CY2021Q4 | us-gaap |
Direct Financing Lease Deferred Selling Profit
DirectFinancingLeaseDeferredSellingProfit
|
1380000 | |
CY2020Q4 | us-gaap |
Direct Financing Lease Deferred Selling Profit
DirectFinancingLeaseDeferredSellingProfit
|
1422000 | |
CY2021Q4 | mnkd |
Current Portion Of Milestone Right Liability
CurrentPortionOfMilestoneRightLiability
|
1088000 | |
CY2020Q4 | mnkd |
Current Portion Of Milestone Right Liability
CurrentPortionOfMilestoneRightLiability
|
1337000 | |
CY2021Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
895000 | |
CY2020Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
533000 | |
CY2021Q4 | mnkd |
Retail Inventory Purchase
RetailInventoryPurchase
|
-875000 | |
CY2021Q4 | us-gaap |
Construction Payable Current
ConstructionPayableCurrent
|
786000 | |
CY2021Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
1980000 | |
CY2021Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
134273000 | |
CY2020Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
122687000 | |
CY2021Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
97661000 | |
CY2020Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
96820000 | |
CY2021Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
36612000 | |
CY2020Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
25867000 | |
CY2021 | us-gaap |
Depreciation
Depreciation
|
2000000.0 | |
CY2021Q4 | us-gaap |
Senior Notes
SeniorNotes
|
223944000 | |
CY2021Q4 | us-gaap |
Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
|
18425000 | |
CY2020Q4 | us-gaap |
Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
|
63027000 | |
CY2021Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
281202000 | |
CY2020Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
122235000 | |
CY2021Q4 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
|
6667000 | |
CY2021Q4 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
|
20000000 | |
CY2021Q4 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
|
31758000 | |
CY2021Q4 | mnkd |
Long Term Debt Maturities Repayments Of Principal After Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearThree
|
230000000 | |
CY2021Q4 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
288425000 | |
CY2021Q4 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
1167000 | |
CY2021Q4 | us-gaap |
Deferred Finance Costs Net
DeferredFinanceCostsNet
|
6056000 | |
CY2021 | us-gaap |
Debt Instrument Frequency Of Periodic Payment
DebtInstrumentFrequencyOfPeriodicPayment
|
Principal on each term loan advance under Tranche 1, Tranche 2 and, if applicable, Tranche 3 is payable in 24 equal monthly installments beginning September 1, 2023, until paid in full on August 1, 2025. | |
CY2021Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
281202000 | |
CY2020Q4 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
34937000 | |
CY2019Q3 | us-gaap |
Debt Instrument Maturity Date
DebtInstrumentMaturityDate
|
2024-11-03 | |
CY2021 | mnkd |
Amortization Of Debt Discount
AmortizationOfDebtDiscount
|
377000 | |
CY2020 | mnkd |
Amortization Of Debt Discount
AmortizationOfDebtDiscount
|
268000 | |
CY2021 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
1215000 | |
CY2020 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
101000 | |
CY2021Q4 | mnkd |
Milestone Rights Liabilities Current And Noncurrent
MilestoneRightsLiabilitiesCurrentAndNoncurrent
|
5900000 | |
CY2020Q4 | mnkd |
Milestone Rights Liabilities Current And Noncurrent
MilestoneRightsLiabilitiesCurrentAndNoncurrent
|
7300000 | |
CY2020 | mnkd |
Payment For Milestone Rights Liabilities
PaymentForMilestoneRightsLiabilities
|
5000000.0 | |
CY2021Q2 | us-gaap |
Debt Instrument Maturity Date
DebtInstrumentMaturityDate
|
2025-12-31 | |
CY2021Q4 | mnkd |
Milestone Rights Liability Current
MilestoneRightsLiabilityCurrent
|
1300000 | |
CY2019Q4 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
40847000 | |
CY2021 | mnkd |
Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
|
21707000 | |
CY2020 | mnkd |
Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
|
1910000 | |
CY2020 | mnkd |
Contract With Customer Liability Upfront And Milestone Payments
ContractWithCustomerLiabilityUpfrontAndMilestonePayments
|
25000000 | |
CY2021 | mnkd |
Contract With Customer Liability Collaborations And Services Revenue
ContractWithCustomerLiabilityCollaborationsAndServicesRevenue
|
-36274000 | |
CY2020 | mnkd |
Contract With Customer Liability Collaborations And Services Revenue
ContractWithCustomerLiabilityCollaborationsAndServicesRevenue
|
-32820000 | |
CY2021Q4 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
20370000 | |
CY2020Q4 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
34937000 | |
CY2021Q4 | us-gaap |
Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
|
50900000 | |
CY2021 | us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
5000000.0 | |
CY2021Q4 | us-gaap |
Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
|
7000000.0 | |
CY2021Q4 | us-gaap |
Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
|
93500000 | |
CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
400000000 | |
CY2021Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2021Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | |
CY2021Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
CY2021Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
251477562 | |
CY2021Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
251477562 | |
CY2020Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
242117089 | |
CY2020Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
242117089 | |
CY2020Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2021Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2021 | us-gaap |
Proceeds From Stock Plans
ProceedsFromStockPlans
|
100000 | |
CY2021 | mnkd |
Market Price Stock Purchase Plan
MarketPriceStockPurchasePlan
|
25000 | |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-80926000 | |
CY2020 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-57240000 | |
CY2021 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
249244000 | |
CY2020 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
222585000 | |
CY2021 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.32 | |
CY2020 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.26 | |
CY2021 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
69998009 | |
CY2020 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
32745273 | |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
10655146 | |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
7609025 | |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
|
5344810 | |
CY2021 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
12200000 | |
CY2020 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
6511000 | |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
|
0 | |
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
3.41 | |
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
15414000 | |
CY2021 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
586572 | |
CY2021 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
1.72 | |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
258410 | |
CY2021 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
1.59 | |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
764488 | |
CY2021 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
11.57 | |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
10655146 | |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
2.96 | |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
25458000 | |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
8009961 | |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
3.40 | |
CY2021Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
18436000 | |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
|
0 | |
CY2020 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
970000 | |
CY2021 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
|
2300000 | |
CY2020 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
|
4500000 | |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
1700000 | |
CY2020 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
500000 | |
CY2021 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
1000000.0 | |
CY2021 | mnkd |
Interest Expense On Financing Liability
InterestExpenseOnFinancingLiability
|
1373000 | |
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
6037542 | |
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
2.20 | |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
|
3326798 | |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
5.82 | |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
|
1516065 | |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
|
2.22 | |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
|
239250 | |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
|
2.58 | |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
7609025 | |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
3.77 | |
CY2020 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
|
2500000 | |
CY2020Q4 | mnkd |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options In Period Grant Date Fair Value Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsInPeriodGrantDateFairValueOutstanding
|
13300000 | |
CY2021Q4 | us-gaap |
Finance Lease Liability
FinanceLeaseLiability
|
100500000 | |
CY2021Q4 | us-gaap |
Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
|
93500000 | |
CY2021Q4 | us-gaap |
Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
|
7000000.0 | |
CY2021Q4 | us-gaap |
Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
|
0.090 | |
CY2021Q4 | mnkd |
Finance Lease Liability Discounted Payments Due Next Twelve Months
FinanceLeaseLiabilityDiscountedPaymentsDueNextTwelveMonths
|
6373000 | |
CY2021Q4 | mnkd |
Finance Lease Liability Discounted Payments Due Year Two
FinanceLeaseLiabilityDiscountedPaymentsDueYearTwo
|
9778000 | |
CY2021Q4 | mnkd |
Finance Lease Liability Discounted Payments Due Year Three
FinanceLeaseLiabilityDiscountedPaymentsDueYearThree
|
10023000 | |
CY2021Q4 | mnkd |
Finance Lease Liability Discounted Payments Due Year Four
FinanceLeaseLiabilityDiscountedPaymentsDueYearFour
|
10274000 | |
CY2021Q4 | mnkd |
Finance Lease Liability Discounted Payments Due Year Five
FinanceLeaseLiabilityDiscountedPaymentsDueYearFive
|
10539000 | |
CY2021Q4 | mnkd |
Finance Lease Liability Discounted Payments Due After Year Five
FinanceLeaseLiabilityDiscountedPaymentsDueAfterYearFive
|
199091000 | |
CY2021Q4 | mnkd |
Finance Lease Liability Discounted Payments Due
FinanceLeaseLiabilityDiscountedPaymentsDue
|
246078000 | |
CY2021Q4 | mnkd |
Finance Lease Liability Discounted Excess Amount
FinanceLeaseLiabilityDiscountedExcessAmount
|
142485000 | |
CY2021Q4 | mnkd |
Finance Lease Liability Discounted Debt Issuance Costs
FinanceLeaseLiabilityDiscountedDebtIssuanceCosts
|
3091000 | |
CY2021Q4 | mnkd |
Finance Lease Liability Discounted
FinanceLeaseLiabilityDiscounted
|
100502000 | |
CY2021 | mnkd |
Payment Of Long Term Purchase Commitment Amendment Fee
PaymentOfLongTermPurchaseCommitmentAmendmentFee
|
2000000.0 | |
CY2021Q4 | us-gaap |
Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
|
5400000 | |
CY2021Q1 | us-gaap |
Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
|
7000000.0 | |
CY2021Q4 | us-gaap |
Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
|
8800000 | |
CY2021Q1 | us-gaap |
Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
|
8500000 | |
CY2021Q4 | us-gaap |
Purchase Obligation Due In Third Year
PurchaseObligationDueInThirdYear
|
14600000 | |
CY2021Q1 | us-gaap |
Purchase Obligation Due In Third Year
PurchaseObligationDueInThirdYear
|
10900000 | |
CY2021Q4 | us-gaap |
Purchase Obligation Due In Fourth Year
PurchaseObligationDueInFourthYear
|
15500000 | |
CY2021Q1 | us-gaap |
Purchase Obligation Due In Fourth Year
PurchaseObligationDueInFourthYear
|
14600000 | |
CY2021Q4 | us-gaap |
Purchase Obligation Due In Fifth Year
PurchaseObligationDueInFifthYear
|
19400000 | |
CY2021Q1 | us-gaap |
Purchase Obligation Due In Fifth Year
PurchaseObligationDueInFifthYear
|
15500000 | |
CY2021Q4 | mnkd |
Purchase Obligation Due In Sixth Year
PurchaseObligationDueInSixthYear
|
9200000 | |
CY2021Q1 | mnkd |
Purchase Obligation Due In Sixth Year
PurchaseObligationDueInSixthYear
|
19400000 | |
CY2021 | mnkd |
Long Term Purchase Commitment Expiration Date
LongTermPurchaseCommitmentExpirationDate
|
2027-12-31 | |
CY2021Q4 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.073 | |
CY2020Q4 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.075 | |
CY2021 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
863000 | |
CY2020 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
1403000 | |
CY2021 | us-gaap |
Variable Lease Cost
VariableLeaseCost
|
515000 | |
CY2020 | us-gaap |
Variable Lease Cost
VariableLeaseCost
|
394000 | |
CY2021 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
1867000 | |
CY2020 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
1797000 | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
|
79455000 | |
CY2020Q4 | mnkd |
Deferred Tax Assets Tax Deferred Expense Accrual Adjustment
DeferredTaxAssetsTaxDeferredExpenseAccrualAdjustment
|
1436000 | |
CY2021Q4 | mnkd |
Deferred Tax Assets Loss On Purchase Commitment
DeferredTaxAssetsLossOnPurchaseCommitment
|
24845000 | |
CY2021 | us-gaap |
Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
|
1500000 | |
CY2020 | us-gaap |
Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
|
900000 | |
CY2020 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
-4377000 | |
CY2021 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
-14461000 | |
CY2020 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
-469000 | |
CY2021 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-19631000 | |
CY2020 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-4846000 | |
CY2021 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
-19631000 | |
CY2020 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
-4846000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
542800000 | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
533448000 | |
CY2021 | us-gaap |
Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
|
0.50 | |
CY2020 | us-gaap |
Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
|
0.50 | |
CY2021 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
-80926000 | |
CY2020 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
-57458000 | |
CY2021 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-80926000 | |
CY2020 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-57458000 | |
CY2020 | us-gaap |
Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
|
-218000 | |
CY2020 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
-218000 | |
CY2021 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
-5170000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
|
78804000 | |
CY2021Q4 | mnkd |
Deferred Tax Assets Milestone Rights
DeferredTaxAssetsMilestoneRights
|
1440000 | |
CY2020Q4 | mnkd |
Deferred Tax Assets Milestone Rights
DeferredTaxAssetsMilestoneRights
|
1547000 | |
CY2021Q4 | mnkd |
Deferred Tax Assets Tax Deferred Expense Accrual Adjustment
DeferredTaxAssetsTaxDeferredExpenseAccrualAdjustment
|
2591000 | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
3766000 | |
CY2020Q4 | mnkd |
Deferred Tax Assets Loss On Purchase Commitment
DeferredTaxAssetsLossOnPurchaseCommitment
|
23864000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
5684000 | |
CY2021Q4 | mnkd |
Deferred Tax Assets Capitalized Costs
DeferredTaxAssetsCapitalizedCosts
|
7518000 | |
CY2020Q4 | mnkd |
Deferred Tax Assets Capitalized Costs
DeferredTaxAssetsCapitalizedCosts
|
5273000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
|
2568000 | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
|
2093000 | |
CY2021Q4 | mnkd |
Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
|
588000 | |
CY2020Q4 | mnkd |
Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
|
559000 | |
CY2021Q4 | mnkd |
Deferred Tax Assets Interest Expense Limitation
DeferredTaxAssetsInterestExpenseLimitation
|
5696000 | |
CY2020Q4 | mnkd |
Deferred Tax Assets Interest Expense Limitation
DeferredTaxAssetsInterestExpenseLimitation
|
2460000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
22983000 | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
20735000 | |
CY2021Q4 | mnkd |
Deferred Tax Assets Product Revenue And Costs
DeferredTaxAssetsProductRevenueAndCosts
|
404000 | |
CY2020Q4 | mnkd |
Deferred Tax Assets Product Revenue And Costs
DeferredTaxAssetsProductRevenueAndCosts
|
1569000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
695921000 | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
676205000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
695094000 | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
675463000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
827000 | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
742000 | |
CY2021Q4 | mnkd |
Deferred Tax Liabilities Right Of Use Asset
DeferredTaxLiabilitiesRightOfUseAsset
|
555000 | |
CY2020Q4 | mnkd |
Deferred Tax Liabilities Right Of Use Asset
DeferredTaxLiabilitiesRightOfUseAsset
|
510000 | |
CY2021Q4 | us-gaap |
Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
|
272000 | |
CY2020Q4 | us-gaap |
Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
|
232000 | |
CY2021Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
827000 | |
CY2020Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
742000 | |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.210 | |
CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.210 | |
CY2021 | mnkd |
Effective Income Tax Rate Reconciliation Permanent Items
EffectiveIncomeTaxRateReconciliationPermanentItems
|
-0.044 | |
CY2020 | mnkd |
Effective Income Tax Rate Reconciliation Permanent Items
EffectiveIncomeTaxRateReconciliationPermanentItems
|
-0.061 | |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
|
0.003 | |
CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
|
-0.005 | |
CY2021 | mnkd |
Effective Income Tax Rate Reconciliation Expirations Of Attribute
EffectiveIncomeTaxRateReconciliationExpirationsOfAttribute
|
-0.059 | |
CY2020 | mnkd |
Effective Income Tax Rate Reconciliation Expirations Of Attribute
EffectiveIncomeTaxRateReconciliationExpirationsOfAttribute
|
-0.066 | |
CY2021 | mnkd |
Effective Income Tax Rate Reconciliation Foreign Withholding Tax
EffectiveIncomeTaxRateReconciliationForeignWithholdingTax
|
0.000 | |
CY2020 | mnkd |
Effective Income Tax Rate Reconciliation Foreign Withholding Tax
EffectiveIncomeTaxRateReconciliationForeignWithholdingTax
|
0.004 | |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
0.112 | |
CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
0.078 | |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
0.002 | |
CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
0.000 | |
CY2021 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.000 | |
CY2020 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.004 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
695100000 | |
CY2021 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
-19600000 | |
CY2020 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
-4800000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
|
2200000000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
|
1300000000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
|
452700000 | |
CY2021 | us-gaap |
Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
|
Pursuant to IRC Sections 382 and 383, annual use of the Company’s federal and California net operating loss and research and development credit carryforwards may be limited in the event a cumulative change in ownership of more than 50% occurs within a three-year period. | |
CY2004Q3 | mnkd |
Operating Loss Carryforwards Subject To Limitation
OperatingLossCarryforwardsSubjectToLimitation
|
216000000.0 | |
CY2004Q3 | mnkd |
Net Operating Loss Carryforward Annual Limitation
NetOperatingLossCarryforwardAnnualLimitation
|
13000000.0 | |
CY2021 | mnkd |
Research And Development Credits Begin To Expire
ResearchAndDevelopmentCreditsBeginToExpire
|
2021 | |
CY2021Q4 | mnkd |
Deferred Tax Assets Tax Credit Carryforwards Research Expire
DeferredTaxAssetsTaxCreditCarryforwardsResearchExpire
|
1200000 | |
CY2020Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
268902000 | |
CY2021 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
|
0 | |
CY2020 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
|
268902000 | |
CY2021Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
268902000 | |
CY2020Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
268902000 | |
CY2021 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
|
0 | |
CY2020 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
|
0 |